abstract |
The invention provides aqueous liquid pharmaceutical compositions comprising arbekacin and chloride ions. The compositions are well tolerable for use in a method for the treatment or prevention of a disease of the upper and lower respiratory tract, wherein the composition is aerosolized and inhaled by the patient. In addition, the invention provides arbekacin hydrochloride. |